Join to View Full Profile
1314 N Macomb StMonroe, MI 48162
Phone+1 734-242-6872
Fax+1 734-242-4962
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Mehregan, MD is a board certified dermatologist in Monroe, Michigan. He is currently licensed to practice medicine in Arizona, Iowa, and Idaho. He is affiliated with Intermountain Medical Center, Alta View Hospital, and LDS Hospital.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Dermatopathology, 1990 - 1991- Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 1987 - 1990
Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1986 - 1987
Wayne State University School of MedicineClass of 1982
Certifications & Licensure
UT State Medical License 2005 - 2026
OH State Medical License 1991 - 2021
AZ State Medical License 2011 - 2020
IA State Medical License 2011 - 2020
ID State Medical License 2011 - 2020
IL State Medical License 2011 - 2020
NY State Medical License 2011 - 2020
American Board of Dermatology Dermatology- American Board of Dermatology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsInterstitial granulomatous dermatitis and palisaded neutrophilic granulomatous dermatitis.Taryn Huizenga, Jessica Kado, Brenda L Pellicane, Judy H. Borovicka, Darius R. Mehregan
Cutis. 2018-05-01 - Itchy bumps with new-onset bullae.Syed Hamzah Mahmood, Anthony Van Vreede, David A. Mehregan
Pediatric Dermatology. 2018-01-01 - 2 citationsSacral zoster with a primary complaint of difficulty voidingJeremy A. Grekin, David A. Mehregan
JAAD Case Reports. 2017-11-01
Press Mentions
Pulse Biosciences Announces Positive Results from Its First Study Evaluating a Clinical Target at Major Scientific MeetingApril 12th, 2018
